A detailed history of Cibc World Markets Corp transactions in Mannkind Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 37,307 shares of MNKD stock, worth $207,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,307
Previous 59,758 37.57%
Holding current value
$207,053
Previous $300,000 53.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$3.71 - $5.04 $83,293 - $113,153
-22,451 Reduced 37.57%
37,307 $139,000
Q1 2025

May 13, 2025

BUY
$4.92 - $6.6 $170,005 - $228,056
34,554 Added 137.1%
59,758 $300,000
Q4 2024

Feb 10, 2025

BUY
$5.93 - $7.44 $149,459 - $187,517
25,204 New
25,204 $162,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.43B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.